Jim Rogers, who retired from the Quantum Fund, cofounded with George Soros, at age 37 and is well known for his insight into commodity markets, seems pretty bearish these days on...
In 2014, Dixie Brands, then known as Dixie Elixirs, was valued at $40mm at the time it raised $8mm. In an interview with Bloomberg, CEO Tripp Keber suggested that...
Another day, another deal in Canada! In advance of legalization and facing a shortage of capacity to meet the potential demand in the future, the licensed producers (LPs) have...
Analysis of COGS for Canna-Business Owners Guest post by Derek Davis, CPA Cost of Goods Sold (COGS) deductions can offer some substantial tax savings for your business, as the...
Emblem Cannabis Corp. Poised to Change Canada’s Medical Marijuana Industry TORONTO, ONTARIO–(Marketwired – Aug. 3, 2016) – Emblem Cannabis Corp., with production facilities in Paris, Ontario, becomes the latest...
This is a big month for Canada’s federal medical cannabis program, MMPR, as Health Canada must respond to the Allard ruling by August 24th, paving the way for home...
On its weekly Cannabist Show, Ricardo Baca interviewed Scott Thorn, COO of The Clinic, which just moved from its New Mexico Avenue location to a new one at 2020 S. Colorado,...
The balance of 2016 offers significant potential changes for the Canadian medical cannabis program, MMPR, in August as well as the first hint at what the pending legislation for...
The pesticide crisis that has burdened Colorado’s cannabis industry since last September continues to persist but is perhaps nearing its end. While Colorado’s regulators continue to struggle with the...
One of the biggest headaches for cannabis companies is the scarcity of banks willing to take their cash cash deposits, which are substantial given the nature of the business....
Nevada Attorney General Adam Laxalt issued two opinions this week to Richard Whitley, Director of the Department of Health and Human Services, which oversees the medical cannabis program in the state....
Earlier this week, MassRoots (OTC: MSRT) revealed that it is targeting competitors Leafly and Weedmaps with the introduction of its Dispensary Finder service. The company introduced the offering with a discounted...
Low-Income Users*: A Worthwhile Investment Guest post by Bethany Gomez and Jamie Schau of the Brightfield Group In considering potential markets to target, investors might overlook low-income consumers given their limited...
Canadian licensed producers (LPs) continue to raise capital aggressively as the MMPR program takes off and in front of legalization. Aphria (TSXV: APH) (OTC: APHQF) announced its second deal since...
There are few, if any, good examples of an established cannabis brand being acquired by a publicly-traded company, and one of the worst examples was the purchase of Bhang...
We continue to caution investors in the cannabis industry that too many bad actors trying to raise millions of dollars are running rampant. Last week, we examined Cultivation Technologies...
With the completion of two Phase 3 clinical trials that showed its Epidiolex to be safe and effective, global interest in GW Pharma’s (NASDAQ: GWPH) pharmaceutical-grade cannabidiol (CBD) extracted from cannabis continues...
Alison Malsbury of Canna Law Group is cautious on CBD for pets from a legal perspective. While her blog post certainly isn’t definitive, she raises several issues that suggest...
PharmaCielo, a Canadian company that wholly owns PharmaCielo Colombia Holdings S.A.S, continues to scale up its cannabis operations in Colombia. The company reported today that it has purchased a...
Canadian licensed cannabis producer Aphria (TSXV: APH) (OTC: APHQF) announced today a $6mm financing at very attractive terms. WFCU Credit Union, based in Windsor and the sixth largest credit...
